A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine

Biomaterials

Volumn 33, Issue 7, 2012, Pages 2372-2387

  Lai, Jui Yang ^a   Hsieh, Ai Ching ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Biodegradable in situ forming gel; Gelatin g PNIPAAm; Glaucoma therapy; Intracameral delivery system; Pilocarpine

Indexed keywords

ANTERIOR SEGMENT; BIOMICROSCOPY; COUPLING REACTION; CYTOCOMPATIBILITY; DEGREE OF GRAFTING; DELIVERY SYSTEMS; ENCAPSULATION EFFICIENCY; EYE DROPS; FEED MOLAR RATIO; FOURIER TRANSFORM INFRARED; GELATIN-G-PNIPAAM; GELATINASE; GLAUCOMA THERAPY; GRAFTING RATIO; IN-SITU FORMING; IN-SITU-GELLING; INTRA OCULAR PRESSURE; N-ISOPROPYLACRYLAMIDES; PHARMACOLOGICAL RESPONSE; PHASE TRANSITION PROPERTIES; PILOCARPINE; PUPIL SIZE; THERMAL GELATION; TIME POINTS; WEIGHT RATIOS;

ACRYLIC MONOMERS; AMIDES; BIOCHEMISTRY; CELL CULTURE; CHEMICAL BONDS; COAGULATION; DEGRADATION; ENCAPSULATION; ENDOTHELIAL CELLS; GELATION; GELS; GRAFT COPOLYMERS; OPHTHALMOLOGY;

GRAFTING (CHEMICAL);

COPOLYMER; EYE DROPS; GELATIN; GELATINASE; PILOCARPINE; POLY(N ISOPROPYLACRYLAMIDE);

ANIMAL MODEL; ARTICLE; BIODEGRADATION; BIOMICROSCOPY; CELL PROLIFERATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; ENCAPSULATION; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; GLAUCOMA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRAOCULAR PRESSURE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PUPIL; TEMPERATURE;

ACRYLAMIDES; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELATIN; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MATERIALS TESTING; MIOTICS; MOLECULAR STRUCTURE; OPHTHALMIC SOLUTIONS; PILOCARPINE; POLYMERS; RABBITS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

ORYCTOLAGUS CUNICULUS;

EID: 84855732826     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.085     Document Type: Article

References (57)

1. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006, 90:262-267.
2. de la Fuente M., Raviña M., Paolicelli P., Sanchez A., Seijo B., Alonso M.J. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 2010, 62:100-117.
3. ®: a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharm 1989, 57:163-168.
4. Cohen S., Lobel E., Trevgoda A., Peled Y. Anovel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. JControl Release 1997, 44:201-208.
5. Lin H.R., Yu S.P., Kuo C.J., Kao H.J., Lo Y.L., Lin Y.J. Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery. JBiomater Sci Polym Ed 2007, 18:205-221.
6. Srividya B., Cardoza R.M., Amin P.D. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. JControl Release 2001, 73:205-211.
7. Hsiue G.H., Hsu S.H., Yang C.C., Lee S.H., Yang I.K. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. Biomaterials 2002, 23:457-462.
8. El-Kamel A.H. Invitro and invivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm 2002, 241:47-55.
9. Gaudana R., Ananthula H.K., Parenky A., Mitra A.K. Ocular drug delivery. AAPS J 2010, 12:348-360.
10. Hironaka K., Inokuchi Y., Tozuka Y., Shimazawa M., Hara H., Takeuchi H. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. JControl Release 2009, 136:247-253.
11. Aliyar H.A., Hamilton P.D., Ravi N. Refilling of ocular lens capsule with copolymeric hydrogel containing reversible disulfide. Biomacromolecules 2005, 6:204-211.
12. Turturro S.B., Guthrie M.J., Appel A.A., Drapala P.W., Brey E.M., Pérez-Luna V.H., et al. The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function. Biomaterials 2011, 32:3620-3626.
13. Davidorf F.H., Chambers R.B., Kwon O.W., Doyle W., Gresak P., Frank S.G. Ocular toxicity of vitreal pluronic polyol F-127. Retina 1990, 10:297-300.
14. Lai J.Y. Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use. JMater Sci Mater Med 2010, 21:1899-1911.
15. Lai J.Y., Lu P.L., Chen K.H., Tabata Y., Hsiue G.H. Effect of charge and molecular weight on the functionality of gelatin carriers for corneal endothelial cell therapy. Biomacromolecules 2006, 7:1836-1844.
16. Lai J.Y., Lin P.K., Hsiue G.H., Cheng H.Y., Huang S.J., Li Y.T. Low Bloom strength gelatin as a carrier for potential use in retinal sheet encapsulation and transplantation. Biomacromolecules 2009, 10:310-319.
17. ® matrices. Pharm Res 1993, 10:109-112.
18. Vandervoort J., Ludwig A. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm 2004, 57:251-261.
19. Hori K., Sotozono C., Hamuro J., Yamasaki K., Kimura Y., Ozeki M., et al. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. JControl Release 2007, 118:169-176.
20. Tan H., Ramirez C.M., Miljkovic N., Li H., Rubin J.P., Marra K.G. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 2009, 30:6844-6853.
21. Lai J.Y., Li Y.T. Evaluation of cross-linked gelatin membranes as delivery carriers for retinal sheets. Mater Sci Eng C 2010, 30:677-685.
22. Chen J.P., Cheng T.H. Thermo-responsive chitosan-graft-poly(N-isopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells. Macromol Biosci 2006, 6:1026-1039.
23. Ma D.H.K., Lai J.Y., Cheng H.Y., Tsai C.C., Yeh L.K. Carbodiimide cross-linked amniotic membranes for cultivation of limbal epithelial cells. Biomaterials 2010, 31:6647-6658.
24. Ohya S., Matsuda T. Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: molecular and formulation parameters vs. cell proliferation potential. JBiomater Sci Polym Ed 2005, 16:809-827.
25. Zhang X.Z., Yang Y.Y., Chung T.S., Ma K.X. Preparation and characterization of fast response macroporous poly(N-isopropylacrylamide) hydrogels. Langmuir 2001, 17:6094-6099.
26. Trudel J., Massia S.P. Assessment of the cytotoxicity of photocrosslinked dextran and hyaluronan-based hydrogels to vascular smooth muscle cells. Biomaterials 2002, 23:3299-3307.
27. Lu P.L., Lai J.Y., Ma D.H.K., Hsiue G.H. Carbodiimide cross-linked hyaluronic acid hydrogels as cell sheet delivery vehicles: characterization and interaction with corneal endothelial cells. JBiomater Sci Polym Ed 2008, 19:1-18.
28. Lai J.Y., Chen K.H., Hsu W.M., Hsiue G.H., Lee Y.H. Bioengineered human corneal endothelium for transplantation. Arch Ophthalmol 2006, 124:1441-1448.
29. Lai J.Y. The role of Bloom index of gelatin on the interaction with retinal pigment epithelial cells. Int J Mol Sci 2009, 10:3442-3456.
30. Percicot C.L., Schnell C.R., Debon C., Hariton C. Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrine. JPharmacol Toxicol Methods 1996, 36:223-228.
31. Tan H., Chu C.R., Payne K.A., Marra K.G. Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 2009, 30:2499-2506.
32. Fujimoto K.L., Ma Z., Nelson D.M., Hashizume R., Guan J., Tobita K., et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 2009, 30:4357-4368.
33. Fitzpatrick S.D., Jafar Mazumder M.A., Lasowski F., Fitzpatrick L.E., Sheardown H. PNIPAAm-grafted-collagen as an injectable, in situ gelling, bioactive cell delivery scaffold. Biomacromolecules 2010, 11:2261-2267.
34. Cao Y., Zhang C., Shen W., Cheng Z., Yu L.L., Ping Q. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. JControl Release 2007, 120:186-194.
35. Hsiue G.H., Lai J.Y., Chen K.H., Hsu W.M. Anovel strategy for corneal endothelial reconstruction with a bioengineered cell sheet. Transplantation 2006, 81:473-476.
36. Lai J.Y., Chen K.H., Hsiue G.H. Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials. Transplantation 2007, 84:1222-1232.
37. Lai J.Y., Li Y.T. Influence of cross-linker concentration on the functionality of carbodiimide cross-linked gelatin membranes for retinal sheet carriers. JBiomater Sci Polym Ed 2011, 22:277-295.
38. Pickford A.R., Potts J.R., Bright J.R., Phan I., Campbell I.D. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. Structure 1997, 5:359-370.
39. Lai J.Y., Li Y.T. Functional assessment of cross-linked porous gelatin hydrogels for bioengineered cell sheet carriers. Biomacromolecules 2010, 11:1387-1397.
40. Morikawa N., Matsuda T. Thermoresponsive artificial extracellular matrix: N-isopropylacrylamide-graft-copolymerized gelatin. JBiomater Sci Polym Ed 2002, 13:167-183.
41. Dinçer S., Tuncel A., Pişkin E. Apotential gene delivery vector: N-isopropylacrylamide-ethyleneimine block copolymers. Macromol Chem Phys 2002, 203:1460-1465.
42. Ethier C.R., Kamm R.D., Johnson M., Pavao A.F., Anderson P.J. Further studies on the flow of aqueous humor through microporous filters. Invest Ophthalmol Vis Sci 1989, 30:739-746.
43. Gao C., Möhwald H., Shen J. Thermosensitive poly(allylamine)-g-poly(N-isopropylacrylamide): synthesis, phase separation and particle formation. Polymer 2005, 46:4088-4097.
44. Xu X.D., Wang B., Wang Z.C., Cheng S.X., Zhang X.Z., Zhuo R.X. Fabrication of fast responsive, thermosensitive poly(N-isopropylacrylamide) hydrogels by using diethyl ether as precipitation agent. JBiomed Mater Res A 2008, 86:1023-1032.
45. Vernon B., Kim S.W., Bae Y.H. Thermoreversible copolymer gels for extracellular matrix. JBiomed Mater Res 2000, 51:69-79.
46. Schmaljohann D., Oswald J., Jørgensen B., Nitschke M., Beyerlein D., Werner C. Thermo-responsive PNiPAAm-g-PEG films for controlled cell detachment. Biomacromolecules 2003, 4:1733-1739.
47. Liu X.M., Wang L.S., Wang L., Huang J., He C. The effect of salt and pH on the phase-transition behaviors of temperature-sensitive copolymers based on N-isopropylacrylamide. Biomaterials 2004, 25:5659-5666.
48. Harper E., Berger A., Katchalski E. The hydrolysis of poly (l-Prolyl-Glycyl-l-Prolyl) by bacterial collagenase. Biopolymers 1972, 11:1607-1612.
49. Määttä M., Tervahartiala T., Harju M., Airaksinen J., Autio-Harmainen H., Sorsa T. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. JGlaucoma 2005, 14:64-69.
50. Vihola H., Laukkanen A., Valtola L., Tenhu H., Hirvonen J. Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam). Biomaterials 2005, 26:3055-3064.
51. Yoshida R., Sakai K., Okano T., Sakurai Y. Surface-modulated skin layers of thermal responsive hydrogels as on-off switches: II. Drug permeation. JBiomater Sci Polym Ed 1992, 3:243-252.
52. Hsiue G.H., Guu J.A., Cheng C.C. Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine. Biomaterials 2001, 22:1763-1769.
53. Gelatt K.N. Animal models for glaucoma. Invest Ophthalmol Vis Sci 1977, 16:592-596.
54. Lu P.L., Lai J.Y., Tabata Y., Hsiue G.H. Amethodology based on the " anterior chamber of rabbit eyes" model for noninvasively determining the biocompatibility of biomaterials in an immune privileged site. JBiomed Mater Res A 2008, 86:108-116.
55. Lai J.Y., Ma D.H.K., Cheng H.Y., Sun C.C., Huang S.J., Li Y.T., et al. Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers. JBiomater Sci Polym Ed 2010, 21:359-376.
56. Cho S.W., Kim J.M., Choi C.Y., Park K.H. Changes in corneal endothelial cell density in patients with normal-tension glaucoma. Jpn J Ophthalmol 2009, 53:569-573.
57. Bensinger R., Shin D.H., Kass M.A., Podos S.M., Becker B. Pilocarpine ocular inserts. Invest Ophthalmol 1976, 15:1008-1010.